{
    "Trade/Device Name(s)": [
        "C.f.a.s. DAT Qualitative Plus Clinical",
        "Control Set DAT Clinical"
    ],
    "Submitter Information": "Roche Diagnostics",
    "510(k) Number": "K090939",
    "Predicate Device Reference 510(k) Number(s)": [
        "K031775",
        "K033306",
        "K080183"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DKB",
        "DIF"
    ],
    "Summary Letter Date": "June 18, 2009",
    "Summary Letter Received Date": "April 3, 2009",
    "Submission Date": "April 2, 2009",
    "Regulation Number(s)": [
        "21CFR862.3200",
        "21CFR862.3280"
    ],
    "Regulation Name(s)": [
        "Clinical toxicology control material"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Amphetamines",
        "Barbiturates",
        "Benzodiazepines",
        "Cannabinoids",
        "Cocaine",
        "Methadone",
        "Methaqualone",
        "Opiates",
        "Phencyclidine",
        "Propoxyphene"
    ],
    "Specimen Type(s)": [
        "Human urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Automated clinical chemistry analyzers (Roche)"
    ],
    "Method(s)/Technology(ies)": [
        "Gas chromatography/mass spectrometry (for verification)"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for C.f.a.s. DAT Qualitative Plus Clinical calibrator and Control Set DAT Clinical for drugs of abuse testing in urine on automated chemistry analyzers",
    "Indications for Use Summary": "Calibrator is for qualitative calibration and control set is for assayed control in Roche drug of abuse assays in human urine on automated clinical chemistry analyzers",
    "fda_folder": "Toxicology"
}